A firsthand look at downtown on a Friday in late February reflects the progress made by private investors and their public-sector partners to focus on safety, cleanliness and livability.

Experience From Brazilian and Australian Clinical Trials Positions the Company to Submit Investigational Device Exemption (IDE) to FDA for Novel CBGM Technology in Q2 2026RUTHERFORD, N.J., March 27, ...